Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide
{{output}}
Late radiation-induced kidney toxicity limits molecular radionuclide therapy using radiopharmaceuticals such as 177Lu-octreotate and 177Lu-octreotide. Better kidney protection would allow higher amounts of radiopharmaceutical to be administered. Coadministrati... ...
